The Neurotech Investing and Partnering Conference is the premier partnering and investing conference for the neurotechnology industry, spanning pharmaceuticals, medical devices, software and diagnostics for the brain and nervous system. The Fourth Neurotech Investing and Partnering Conference Europe will take place at the Wyss Center, Campus Biotech, in Geneva, on October 3rd-4th, 2017.
Dr Dirk Beher will be presenter and panellist at the session “Treatment for Alzheimer’s and Cognitive Disorders” on October 3rd, at 10:45 am. He will present O-Glcnacase Inhibitor ASN120290 as Anti-Tau Drug Candidate for Alzheimer’s Disease and Other Tauopathies.

Dirk Beher, CEO, will present on “O-GlcNAcase inhibitors for tauopathies – translation of a research finding to a clinical candidate molecule”.

About EuroTauMeeting

The 1st EuroTauMeeting will be held at the School of Medicine (Faculté de Médecine) in Lille, France, on April 27-28, 2017, with the support of DN2M (Federation in Neurosciences at the Univ. Lille) and LiCEND (Lille Centre of Excellence in Neurodegenerative Disorders).
With the objective to build a European consortium on Tau proteins and Tauopathies, European scientists involved in Tau research will gather during two days to exchange new ideas and hypotheses on physiological and pathological roles of tau proteins.

Dr. Dirk Beher, CEO will present at SYMPOSIUM 05 – TRANSLATIONAL STRATEGIES 1 on 29 March 2017 (Hall E2) from 8:30 to 10:30am.
 

The 13th International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders will take place from 29 March to April 2, 2017 in Vienna, Austria.
The groundbreaking series of Alzheimer’s and Parkinson’s Diseases Conferences attract international medical and scientific professionals worldwide. The Conference is at the forefront of unraveling the mechanisms and improving the treatment of Alzheimer’s, Parkinson’s and other related neurodegenerative diseases. AD/PD Conferences uniquely combine distinct neurodegenerative diseases in one setting and examine their similarities and differences; a strong focus is mechanisms of disease, prevention and therapy.

The 35th Annual J.P. Morgan Healthcare Conference brings together corporate leaders, financial sponsors and institutional investors to explore market and sector trends.

Click here to learn more about JP Morgan conferences

The poster will be presented November 16, 2016, at 2:00 PM:

Session: 786 – Pharmacology for Alzheimer’s Disease Therapeutics
786.10. Estimating receptor occupancy requirements for positive allosteric modulators of the M1 muscarinic acetylcholine receptor as cognitive enhancers
*D. BEHER, A. SAND, M. NÉNY, J. HANTSON, S. OUSSON, B. PERMANNE, A. QUATTROPANI, C. WIESSNER;

About Neuroscience 2016

SfN’s 46^th annual meeting is the premier venue for neuroscientists to present emerging science, learn from experts, collaborate with peers, explore new tools and technologies, and advance careers.

BIO-Europe is Europe’s largest partnering conference serving the global biotechnology industry. This year it will gather more than 3500 attendees with 1800 companies from over 50 countries.